Expression and clinica1l significanceof CCL17,CCL22,and CCR4 in newly diagnosed multiple myeloma  

作　　者：XIAO Zifan 肖姿帆(Dept Hematol,Affil Hosp,Zunyi Med Univ,Zunyi 563000)

机构地区：[1]Dept Hematol,Affil Hosp,Zunyi Med Univ,Zunyi 563000

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第4期226-227,共2页中国医学文摘(内科学分册英文版)

摘　　要：Objective To study the expressions of C-C class chemokine 17(CCL17),C-C class chemokine 22(CCL22),and C-C chemokine receptor 4(CCR4)in newly diagnosed multiple myeloma(NDMM)for analyzing their correlations with clinical features and to preliminarily explore their roles in the development of NDMM.Methods The study included 40 patients with NDMM and 20 healthy volunteers from the Department of Hematology of the Affiliated Hospital of Zunyi Medical University from July 2020 to December 2022.

关 键 词：CCR4 CCL22 CCL17 

分 类 号：R73[医药卫生—肿瘤]